Qlaris Bio

Dedham, MA · Founded 2019 · Privately Held (backing)

Developer of novel therapies designed to treat serious and debilitating ophthalmic diseases. Qlaris Bio is based in Dedham, MA and was founded in 2019. Its last reported valuation was $68 million in Apr 2024. It has raised $55 million across 4 recorded rounds; the latest was a $3.9 million seed round in Jun 2026.

Last reported valuation
$68.0M
Oct 2026
Priced at
—
Total raised
$55.0M
Last round
Seed Round
Jun 2026
What is Qlaris Bio worth?
$68.0Mlast reported valuation · Oct 2026

Qlaris Bio's last reported valuation, Apr 2024. Nothing priced has surfaced since.

Free account
More of Qlaris Bio with a free account
  • ·Watch Qlaris Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Qlaris Bio funding history

4 rounds
DateRoundRaisedPost-money
Jun 2026Seed Round$3.9M▮
Nov 2025Early Stage VC$5.6M▮
Apr 2024Early Stage VC$24.0M▮
Aug 2019Early Stage VC$8.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Qlaris Bio valuation

Qlaris Bio's last reported valuation was $68 million in Apr 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Qlaris Bio raised?

Qlaris Bio has raised $55 million across 4 recorded rounds since 2019. The largest was an $8.2 million early-stage round in Aug 2019; the most recent was a $3.9 million seed round in Jun 2026.

Qlaris Bio has filed 3 Form Ds with the SEC since 2019, most recently in Nov 2025 ($5.6 million sold to 8 investors).

How Qlaris Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Qlaris Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Qlaris Bio

What is Qlaris Bio worth?
Qlaris Bio is valued at $68.0M as of Oct 2026. Qlaris Bio's last reported valuation, Apr 2024. Nothing priced has surfaced since.
How much has Qlaris Bio raised?
Qlaris Bio has raised $55.0M in total funding across 4 recorded rounds.
When did Qlaris Bio last raise?
Qlaris Bio last raised in Jun 2026 (Seed Round), raising $3.9M.